Viewing Study NCT02304367


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-02-28 @ 2:28 PM
Study NCT ID: NCT02304367
Status: COMPLETED
Last Update Posted: 2024-05-06
First Post: 2014-11-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
Sponsor: Kyowa Kirin, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: UX023T-CL201
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators